BioCentury
ARTICLE | Financial News

Erasca extends series A by $22M

March 8, 2019 7:23 PM UTC

Erasca raised additional funds to enable compound in-licensing and accelerate development of its Oncology Pattern Recognition Algorithm (OPRA) for discovering cancer cures.

Erasca Inc. (San Diego, Calif.) raised $22 million in a series A extension, bringing the round's total to $64 million. The extension included new investors Arch Venture Partners, Andreessen Horowitz and Reneo Capital, plus undisclosed investors...

BCIQ Company Profiles

Erasca Inc.